Hospital
Pacific County Hospital District 2
Pacific County Hospital District 2 was paid $10.69M by Medicaid between Jan 2018 and Dec 2024, across 109 billing codes. Its largest line is 99283, emergency room visit (moderate) — 20% of everything it billed.
33Billing provider infoPACIFIC COUNTY HOSPITAL DISTRICT 2
SOUTH BEND, WA 98586
SOUTH BEND, WA 98586
33aNPI1295708683assigned 02/08/2006
33bProvider typeCritical Access Hospital
28Total paid$10.69M
24GClaims131,924
24DCodes billed109
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Critical Access Hospital providers in Washington
Rank by total paid#14 of 30
Median peer was paid$9.10M
This provider vs. median1.2×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 19,352 | $1.17M | |
| 2019 | 21,828 | $1.40M | |
| 2020 | 17,611 | $1.16M | |
| 2021 | 17,281 | $1.30M | |
| 2022 | 19,234 | $1.89M | |
| 2023 | 19,118 | $1.90M | |
| 2024incomplete | 17,500 | $1.87M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 20% | 10,420 | 8,971 | $2.09M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 11% | 4,050 | 3,109 | $1.17M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 11% | 2,476 | 1,992 | $1.17M |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 9.5% | 538 | 484 | $1.02M |
| 70450 | Computed tomography, head or brain; without contrast material | 5.4% | 956 | 829 | $577K |
| 96361 | Intravenous infusion, hydration; each additional hour | 3.7% | 3,163 | 2,242 | $393K |
| 71046 | Radiologic examination, chest; 2 views | 3.7% | 2,910 | 2,544 | $391K |
| 96375 | Therapeutic injection; each additional sequential IV push | 3.4% | 2,636 | 2,040 | $368K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 2.9% | 2,302 | 1,652 | $308K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 2.1% | 1,697 | 1,539 | $223K |
| 80306 | 2.0% | 2,490 | 2,208 | $218K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.9% | 9,901 | 8,224 | $206K |
97 more codes
| 80053 | Comprehensive metabolic panel | 1.9% | 10,013 | $201K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1.5% | 3,527 | $165K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 1.5% | 2,173 | $159K |
| 84443 | Thyroid stimulating hormone (TSH) | 1.5% | 3,774 | $157K |
| 36415 | Collection of venous blood by venipuncture | 1.1% | 10,217 | $117K |
| 71045 | Radiologic examination, chest; single view | 1.0% | 1,315 | $108K |
| 80061 | Lipid panel | <1% | 2,448 | $104K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 1,540 | $89K |
| 84484 | <1% | 2,777 | $88K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 3,152 | $84K |
| 83690 | <1% | 1,957 | $73K | |
| 81001 | <1% | 5,244 | $64K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 2,007 | $60K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 2,275 | $56K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 940 | $55K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,256 | $54K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 127 | $49K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 2,819 | $38K |
| 83880 | <1% | 1,086 | $38K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 967 | $35K |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 1,529 | $33K |
| 84439 | <1% | 1,210 | $33K | |
| 96367 | <1% | 157 | $31K | |
| 82550 | <1% | 1,248 | $30K | |
| 85027 | <1% | 1,496 | $30K | |
| 82553 | <1% | 1,057 | $30K | |
| 83605 | <1% | 1,903 | $29K | |
| 87040 | <1% | 992 | $28K | |
| 80050 | General health panel | <1% | 231 | $28K |
| 83735 | <1% | 1,573 | $28K | |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 902 | $28K |
| 96376 | <1% | 381 | $26K | |
| 87186 | <1% | 447 | $26K | |
| 87070 | <1% | 813 | $25K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 1,201 | $23K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,193 | $23K |
| 85610 | <1% | 1,323 | $21K | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 900 | $18K |
| G0378 | Hospital observation service, per hour | <1% | 28 | $17K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,703 | $17K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 121 | $16K |
| 81025 | <1% | 498 | $14K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,348 | $14K |
| 86140 | <1% | 436 | $14K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 14 | $13K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 123 | $12K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 25 | $11K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 499 | $10K |
| 82077 | <1% | 207 | $10K | |
| 85730 | <1% | 512 | $9K | |
| 87631 | <1% | 40 | $8K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 127 | $8K |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 206 | $7K |
| 73630 | <1% | 37 | $6K | |
| 73562 | <1% | 40 | $6K | |
| 87077 | <1% | 189 | $6K | |
| J2704 | Injection, propofol, 10 mg | <1% | 306 | $6K |
| 84703 | <1% | 235 | $6K | |
| 82150 | <1% | 178 | $5K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 122 | $5K |
| 72100 | <1% | 29 | $5K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 68 | $5K |
| J3490 | Unclassified drugs | <1% | 323 | $4K |
| 85379 | <1% | 135 | $4K | |
| 73030 | <1% | 26 | $4K | |
| 85651 | <1% | 200 | $3K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 14 | $2K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 61 | $2K |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 14 | $2K |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 151 | $2K |
| 87088 | <1% | 72 | $2K | |
| 82607 | <1% | 64 | $2K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 75 | $2K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 25 | $1K |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 50 | $1K |
| 82962 | <1% | 75 | $1K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 674 | $910.81 |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 15 | $823.55 |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | <1% | 14 | $675.06 |
| 87081 | <1% | 33 | $669.20 | |
| 82728 | <1% | 16 | $547.14 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 138 | $530.96 |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | <1% | 12 | $497.02 |
| 90686 | <1% | 15 | $461.13 | |
| 82570 | <1% | 24 | $448.14 | |
| 83540 | <1% | 25 | $429.58 | |
| C9113 | Injection, pantoprazole sodium, per vial | <1% | 32 | $429.15 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 29 | $323.13 |
| 83550 | <1% | 24 | $307.78 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 17 | $289.71 |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 505 | $236.11 |
| 82043 | <1% | 12 | $196.25 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 61 | $122.05 |
| 85007 | <1% | 15 | $97.79 | |
| 80320 | <1% | 137 | $92.59 | |
| 99441 | <1% | 24 | $71.28 | |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 17 | $59.98 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSTONE, TERRY (CFO)